S. Mckenzie

发表

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.

D. Postma, P. Burney, G. Joos, 1999, The European respiratory journal.

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

B. Strandvik, M. Hodson, J. Navarro, 2001, The European respiratory journal.

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF

B. Strandvik, M. Hodson, J. Navarro, 2001 .

Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis

B. Strandvik, M. Hodson, J. Navarro, 2001, Pediatric pulmonology.

Dornase alfa in the treatment of cystic fibrosis in Europe: A report from the Epidemiologic Registry of Cystic Fibrosis

B. Strandvik, M. Hodson, J. Navarro, 2003, Pediatric pulmonology.

International practice patterns by age and severity of lung disease in cystic fibrosis: Data from the epidemiologic registry of cystic fibrosis (ERCF)

M. Hodson, J. Navarro, G. Mastella, 1997, Pediatric pulmonology.

Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis

B. Strandvik, M. Hodson, S. Mckenzie, 2007, Pediatric pulmonology.

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study

B. Strandvik, M. Hodson, J. Navarro, 2000 .

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

B. Strandvik, M. Hodson, J. Navarro, 2000, The European respiratory journal.

Allergic bronchopulmonary aspergillosis in cystic fibrosis.

B. Strandvik, M. Hodson, J. Navarro, 2001, The European respiratory journal.

European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations

B. Strandvik, M. Hodson, J. Navarro, 2001, Pediatric pulmonology.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

J. P. Sy, H. Tiddens, J. Sy, 2001, The Journal of pediatrics.